Our Next Breakthrough Could Be Yours
Working at Alexion is an experience like no other. With a focus on devastating and rare diseases, each endeavor is urgent and every day counts. You’ll have the opportunity to work on one of the most robust and exciting rare disease pipelines in the biopharmaceutical industry, which includes dozens of diverse preclinical programs across a range of therapeutic modalities. Ground-breaking innovation, life-saving therapies and a promising pipeline, all driven by a team with a shared sense of purpose and dedication – that’s Alexion. Join us to achieve the impossible and do what’s never been done before.
Are you ready to Be Alexion? Discover an opportunity that’s right for you. Alexion Careers Page
A career at Alexion is a chance to build on your education at one of the fastest growing companies in the biopharmaceutical industry. Students at all levels can bring new ideas, fresh perspectives,
and a passion for excellence to Alexion. We look forward to the unique talent and enthusiasm you will bring as we continue to deliver life-transforming therapies to patients with devastating
and rare diseases.
Our internship programs are designed to ensure students gain valuable industry and functional experience, work on meaningful and challenging assignments, and build partnerships within their
professional networks. We offer a variety of opportunities across our business for students to achieve a true sense of what it’s like to Be Alexion. Alexion offers internships across multiple degree levels (BA/BS, MA/MS, MBA, PharmD, Ph.D.) and encourage students in any major to explore the diverse career options available within the biotechnology industry.
At Alexion, we see opportunities where others do not. We have the courage to explore what is believed to be impossible, and to create what hasn’t been imagined. We are driven to take on devastating diseases, and settle for nothing short of transformational change because we know patients’ lives are at stake.
Our three values guide our work every day as we open up new worlds of possibility—patient by patient.
There are many factors that set Alexion apart from other companies in the biopharmaceutical space but above all else is the intimate connection we share with patients, driven by our focus on devastating and rare diseases. We operate with intensity and overcome unique challenges to discover new therapies and deliver them to patients whose lives depend on them. This demands resourcefulness, vigor, courage and a great deal of passion. At Alexion, employees have a stake in truly innovative and fulfilling work that other companies simply don’t offer.
Joe was completing his Master’s degree, engaged to be married, and on his way to becoming a professional mixed martial arts competitor when the symptoms began: unexplained fatigue, dark urine, back and stomach pain. After six weeks of numerous blood tests, Joe was referred to a hematologist who diagnosed him with paroxysmal nocturnal hemoglobinuria (PNH) – an ultra-rare, life-threatening blood disorder in which uncontrolled activation of the complement system leads to the chronic destruction of red blood cells. Historically, approximately one-third of patients with PNH do not survive more than five years from the time of diagnosis.
When Joe was diagnosed, he says that he felt like his dreams were nearly shattered. He was worried that he would not have a future with his fiancée and was told he would never be able to compete in contact sports again. With this news, Joe could have simply thrown in the towel, but he didn’t. Instead, he made it his mission to educate himself and his family about PNH. Fortunately for Joe, his doctors were able to manage his PNH.
“I’ve never been one to back down in a fight, but when I was diagnosed with PNH, the prognosis was overwhelming. I had no choice but to view this disease as yet another challenge – one that I had to overcome. If anything, living with PNH has made me appreciate my time even more, and given me more drive to get back to doing what I love to do.”
Today, Joe shares his story with other patients with PNH to give them hope for the future. Joe is living his life on his own terms; he married his college sweetheart, welcomed the birth of two daughters, and is back in his routine.
When an ultrasound revealed that Evie had extremely fragile and transparent bones, doctors told expectant parents John and Lindsey that it was not likely their baby girl would live long after birth. The hours that Evie’s parents expected to have with her turned into weeks, but the baby was gripped by seizures. Then, a routine blood draw revealed that Evie had low alkaline phosphatase (ALP), which enabled them to diagnose her with hypophosphatasia (HPP) – an ultra-rare, genetic, life-threatening metabolic condition that prevents minerals such as calcium and phosphate from being properly deposited in bones.
Her parents were told that Evie’s case was very severe and that there were no approved or effective treatment options. At three months old, Evie was enrolled in a clinical trial to receive an investigational targeted enzyme replacement therapy, and she continues to receive the investigational therapy today.
Evie is, as her mother says, “writing the book on where we go from here. Her story gives other parents with special needs kids hope that they can be okay, and things can be good.”
I have been working at Alexion Pharmaceuticals full-time (More than 3 years)
Company lives thee mission of patient focused
Ever changing, too many people changing positions
I applied through a recruiter. The process took 4 weeks. I interviewed at Alexion Pharmaceuticals.
Alexion made a verbal offer within a week of the onsite interview. The culture was palpable, positive change.
Negotiations were fair.